NCT00015028View on ClinicalTrials.gov

Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

November 30, 1996

Primary Completion Date

December 31, 1996

Study Completion Date

January 31, 1997

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Buprenorphine/naloxone

Trial Locations (1)

45220

Cincinnati MDRU, Cincinnati

All Listed Sponsors
collaborator

Cincinnati MDRU

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00015028 - Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 | Biotech Hunter | Biotech Hunter